The U.S. Food and Drug Administration has approved the first cannabis based epilepsy drug

In Maryland June 25th, the U.S. Food and Drug Administration approved Epidiolex (cannabidiol) CBD oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome. Two rare and severe forms of epilepsy. This is the first FDA approved drug containing cannabidiol (CBD) a derivative of marijuana.  Epidiolex is an oral solution for patients two […]

Read more →

Tags: , , , , , ,